Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release dexmethylphenidate for ADHD (pediatric, Phase III, China)
CTR20150202Phase 3Completed
- Sponsor
- Henan Zhongshuai Pharmaceutical Technology
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmethylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Henan Zhongshuai Pharmaceutical Technology. Started Apr 2015; status: completed.
02
Drugs
dexmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on CTR20150202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150202.